London’s Bloomsbury Theatre to reopen in 2018
The Bloomsbury Theatre in London will reopen in autumn 2018, more than three years after it closed for refurbishment.
The theatre, owned by University College London, closed earlier than planned in June 2015 after asbestos was found in the building.
It was initially thought that the closure would be for less than a year and the venue would reopen in 2016, however the university confirmed early on that this would not happen until 2018.
The 550-seat Bloomsbury will reopen in 2018 following a major redevelopment with plans for it to host an increased number of student society shows and productions.
UCL Culture, which manages the theatre, said the renewal would enable the venue to be hired out.
A statement from UCL said the theatre’s programme of work would create opportunities for collaboration between academics, artists and companies, as well as hosting commercial shows. The venue is also well known on the comedy circuit.
Simon Cane, director of UCL Culture, said: “The closure gave us the opportunity to assess the value of the theatre to UCL and to consider a new operating model.
“I am excited by the opportunity to develop a refreshed approach to our programming where we will mix leading-edge, research-driven, co-produced content with a curated commercial programme.”
A studio theatre opened in 2015 and has continued to operate throughout the main house’s closure.
We need your help…
When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.
The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.
We are fully independent, but this means we rely on revenue from readers to survive.
Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.